Related by context. All words. (Click for frequent words.) 78 BRCA mutation 77 BRCA2 mutations 75 BRCA1 mutation 74 BRCA mutations 74 BRCA1 mutations 73 BRCA2 gene mutation 71 BRCA2 carriers 69 BRCA2 mutation carriers 69 BRCA2 gene mutations 68 BRCA2 gene 67 mutated BRCA1 67 BRCA gene mutation 67 BRCA1 mutation carriers 66 breast cancer gene mutation 66 BRCA1 66 BRCA2 genetic mutations 66 BRCA gene mutations 66 BRCA1 gene 65 ApoE4 gene 65 atypical hyperplasia 64 TGFBR1 * 6A 64 KRAS mutations 64 noncarriers 64 atypia 64 BRCA mutation carriers 64 BRCA2 63 subclinical hyperthyroidism 63 advanced adenoma 63 APOE e4 63 advanced adenomas 63 APOE4 63 ε4 62 BRCA1 gene mutation 62 ApoE4 62 endometrial cancers 62 elevated CRP 62 genetic variant 62 proband 62 BRCA2 breast cancer 62 testicular germ cell 62 familial pancreatic cancer 62 oophorectomy 62 mutation 62 CDH1 61 colorectal neoplasia 61 HNPCC 61 ductal breast cancer 61 serum selenium 61 lobular carcinoma 61 C#Y 61 CC genotype 61 inherited predisposition 61 deleterious mutation 61 lobular cancer 61 BRAF mutation 61 gene mutations 61 BRCA 61 prostate pancreatic 61 TT genotype 61 inherited mutations 61 ApoE4 allele 61 rs# [001] 61 apolipoprotein E 61 APOE ε4 61 germline mutations 61 penetrance 61 BRAC2 60 lobular breast cancer 60 mutated gene 60 TP# mutations 60 adenoma 60 homozygotes 60 heterozygous 60 genes BRCA1 60 CHEK2 60 poorer prognosis 60 breast cancer genes BRCA1 60 apolipoprotein E gene 60 EGFR mutations 60 mutant allele 60 gene mutation 60 Li Fraumeni 60 PALB2 60 HER2 expression 60 PTPN# 60 CDKN2A 60 advanced neoplasia 60 estrogen receptor negative 60 BRCA carriers 59 NNRTI resistance 59 gene variant 59 faulty BRCA2 gene 59 invasive ductal 59 CIN2 + 59 Li Fraumeni syndrome 59 serous ovarian cancer 59 APOE gene 59 basal cell nevus syndrome 59 susceptibility gene 59 hereditary breast cancer 59 CIN3 59 elevated triglyceride levels 59 PCa 59 contralateral breast cancer 59 HNSCC 59 ADPKD 59 chlamydial infection 59 G allele 59 ABCB1 59 K ras mutations 59 chromosomal abnormalities 59 Ashkenazi Jewish 59 GISTs 59 epithelial ovarian cancer 59 BARD1 59 Apolipoprotein E4 59 thrombophilia 59 estrogen receptor ER 59 IgA deficiency 58 homozygous 58 genetic variants associated 58 familial hypercholesterolemia 58 APOE e4 gene 58 situ LCIS 58 TCF#L# gene 58 rs# [002] 58 BRCA genes 58 gene predisposing 58 dizygotic twins 58 recessive mutations 58 variant alleles 58 adenomatous polyps 58 subclinical hypothyroidism 58 intestinal polyps 58 gene variants 58 genetic abnormalities 58 APOE allele 58 BRCA2 genes 58 hormone receptor negative 58 alleles 58 postmenopausal breast cancer 58 seropositivity 58 operable breast cancer 58 KIF6 gene 58 salpingo oophorectomy 58 EGFR mutation 58 anovulatory infertility 58 ductal cancer 58 MYCN amplification 58 lung adenocarcinoma 58 GSTT1 58 TCF#L# 58 ovarian tumors 58 bilateral oophorectomy 58 genetic mutations 58 Fragile X gene 58 microdeletions 58 chronic HBV 58 #q# [002] 58 rs# [003] 57 SLNB 57 atypical ductal hyperplasia 57 mutated K ras 57 thalassemia trait 57 coinfection 57 probands 57 BRAF mutations 57 genetic mutation 57 precancerous cervical 57 genetic polymorphisms 57 pCR 57 VUR 57 aneuploidy 57 HGPIN 57 adenocarcinomas 57 oropharyngeal cancer 57 axillary lymph nodes 57 cryptorchidism 57 tuberculin skin testing 57 prostate cancer CaP 57 activating mutations 57 pre eclamptic 57 Hurthle cell 57 nonpregnant women 57 heterozygotes 57 parous women 57 peritoneal cancer 57 node metastases 57 genes predisposing 57 anaplastic lymphoma kinase 57 colorectal polyps 57 tanned indoors 57 ovarian carcinoma 57 allele 57 deletion 5q 57 narcolepsy cataplexy 57 histological subtype 57 gene BRCA2 57 irregular menstrual cycles 57 confidence interval #.#-#.# 57 poor metabolizers 57 hydroxyvitamin D levels 57 bladder cancers 57 GSTP1 57 BMPR2 57 p# mutations 57 #q# deletion 57 latent TB infection 57 deCODE BreastCancer TM 57 MTHFR 57 gestational hypertension 57 gestational diabetes mellitus 57 G#S mutation 57 spontaneous preterm delivery 57 precursor lesions 56 transferrin saturation 56 MGUS 56 CYP#C# [001] 56 p# mutation 56 tibolone 56 faulty BRCA genes 56 chromosomal disorders 56 breast cancer susceptibility genes 56 renal cell carcinomas 56 MLH1 56 CYP#C# * 56 Uterine cancer 56 pre cancerous polyps 56 abnormal Pap test 56 GSTM1 56 benign breast 56 premenopausal breast cancer 56 chromosomal aberrations 56 BRCA1 BRCA2 56 untreated celiac disease 56 nonmelanoma skin cancers 56 mosaicism 56 MSH2 56 obstructive coronary artery 56 familial ALS 56 bowel cancers 56 BRAF V#E mutation 56 colorectal carcinoma 56 elevated LDL cholesterol 56 hormone receptor positive 56 baseline HbA1c 56 Adjuvant chemotherapy 56 oncogenic HPV 56 HPV# 56 rs# [004] 56 AUDs 56 neural tube defect 56 ovarian cancers 56 CCR5 delta# 56 gene variation 56 BRCA gene 56 neuroblastomas 56 TP# mutation 56 lymph node involvement 56 SE alleles 56 uterine ovarian 56 shorter telomeres 56 uterine cancers 56 thyrotropin levels 56 frequently benign tumor 56 Asymptomatic 56 hereditary hemochromatosis 56 placental malaria 56 #.#ng/ml 56 apolipoprotein E4 56 Hashimoto thyroiditis 56 diffuse gastric 56 chorioamnionitis 56 breast carcinomas 56 Wwox 56 histologic subtype 56 latent tuberculosis infection 56 slow metabolizers 56 HER2 amplification 56 PTEN mutations 56 polycystic ovary syndrome 56 invasive carcinoma 56 MTHFR gene 56 GBA mutations 56 breast ovarian 56 abnormal mammogram 56 colorectal adenomas 56 polyp recurrence 56 APOE 56 nonalcoholic steatohepatitis NASH 56 prostate adenocarcinoma 55 HIV uninfected 55 FMR1 gene 55 anti JCV antibodies 55 estrogen receptor positive 55 abnormal glucose tolerance 55 pancreatic adenocarcinoma 55 MYH9 gene 55 toxoplasma 55 primary ovarian insufficiency 55 chromosome #p# [001] 55 colorectal cancer CRC 55 distal colon cancer 55 nodal metastasis 55 mutations 55 FGFR2 55 haplotype 55 V Leiden 55 Squamous 55 chromosomal alterations 55 benign proliferative breast 55 PITX2 55 ERBB2 55 dopamine receptor gene 55 variant allele 55 TRAF1 C5 55 clinically insignificant 55 leukaemias 55 MetS 55 LQTS 55 K ras gene 55 TACI mutations 55 monozygotic twin 55 nondiabetic 55 polycystic ovary syndrome PCOS 55 precancerous polyp 55 HBsAg 55 breast endometrial 55 cervical intraepithelial neoplasia 55 acrylamide intake 55 cervical carcinoma 55 habitual snoring 55 nonmelanoma skin cancer 55 hepatitis B infection 55 atopy 55 HER2 positive cancers 55 gene APOE 55 perimenopausal women 55 DRB1 * 55 genotyped 55 HER2 receptor 55 coronary artery calcium 55 bowel polyps 55 Colon polyps 55 ASCUS 55 thyroid hormone levels 55 #q# [001] 55 tumor histology 55 malignant neoplasm 55 5 HTTLPR 55 susceptibility genes 55 thyroid nodules 55 genotypic 55 recurrent VTE 55 pg ml 55 distant metastases 55 hepatocellular carcinomas 55 elevated triglycerides 55 mIU L 55 MAOA L 55 antigen PSA 55 Recurrence Score 55 colorectal tumors 55 systemic lupus erythematosus SLE 55 spontaneous preterm birth 55 germline mutation 55 gynecologic malignancy 55 progesterone receptor negative 55 FXTAS 55 atrophic gastritis 55 preeclamptic 55 HER2 positive tumors 55 CaP 55 seronegative 55 breast cancers 55 uveal melanoma 55 mutated genes 55 contralateral breast 55 adenomas 55 CMV infection 55 faulty BRCA1 gene 55 premenopausal 55 fasting triglyceride levels 55 colorectal cancers 54 sporadic ALS 54 genetic variants 54 cervical neoplasia 54 invasive ductal breast cancer 54 genotype 54 JAK2 mutation 54 MLL gene 54 liver transplant recipients 54 basal cell carcinoma BCC 54 HER2 negative 54 familial adenomatous polyposis 54 carotid stenosis 54 colorectal cancer incidence 54 micrometastases 54 cTnT 54 AAT deficiency 54 ErbB2 positive 54 malignant lesions 54 PTEN mutation 54 allele frequencies 54 BCG vaccinated 54 locoregional recurrence 54 mtDNA mutations 54 asymptomatic 54 hormone therapy estrogen 54 distant metastasis 54 autoantibody positive 54 mCRC patients 54 chromosomal rearrangement 54 rheumatoid factor 54 gallstone disease 54 lobular involution 54 tumor subtypes 54 coinfected 54 malignant lymphoma 54 premature ovarian 54 HPV genotypes 54 RhD negative 54 DQB1 * 54 CGG repeats 54 C. trachomatis 54 KRAS wild 54 allele frequency 54 polymorphism 54 chorionic villi 54 endometrial carcinoma 54 invasive breast cancer 54 LRAT 54 SNPs 54 tumor recurrence 54 Epstein Barr virus EBV 54 HBeAg negative 54 UGT#A# * 54 venous thrombosis 54 normal karyotype 54 APOE genotype 54 elevated serum creatinine 54 breast carcinoma 54 intestinal metaplasia 54 PSA velocity 54 OPRM1 gene 54 FGFR2 gene 54 NF1 54 CYP#D# 54 biochemical relapse 54 EGFR mutation status 54 ApoE gene 54 recurrent miscarriages 54 spontaneous mutations 54 HLA B# 54 hepatocellular carcinoma HCC 54 testicular tumors 54 Rh positive 54 dose ionizing radiation 54 myeloproliferative neoplasms 54 colorectal polyp 54 paternally inherited 54 ovarian breast 54 breast cancer gene mutations 54 leiomyomas 54 Heterozygous 54 APOE4 gene 54 neuroblastoma tumors 54 HbF 54 resistant hormone refractory 54 hypermethylated 54 chromosomal anomaly 54 abnormal Pap smear 54 colorectal neoplasms 54 undescended testes 54 precancerous tumors 54 T1DM 54 elevated depressive symptoms 54 HBV infection 54 varicocele 54 premutation 54 lymph node metastases 54 cell carcinomas 54 H. pylori 54 medullary thyroid cancer 54 gastric cancers 54 allelic variants 54 prostate biopsy 54 T2DM 54 prostate specific 54 postoperative delirium 54 neoplasm 54 diagnosed prenatally 54 Folate deficiency 54 NAFLD 54 colorectal adenoma 54 CYP#C# [002] 54 colon tumors 54 sCJD 54 haplotypes 54 preterm delivery 54 chromosome #q# [001] 54 metastatic gastric 54 GPC5 54 CIN2 54 pre menopausal 54 undergone hysterectomy 53 neoplasia 53 causal variants 53 aneuploidies 53 FLT3 mutations 53 singleton pregnancy 53 monozygotic twins 53 sentinel nodes 53 breast pancreatic 53 subclinical 53 recurrent wheezing 53 ApoE 53 ZNF# 53 epithelial tumors 53 bacterial vaginosis 53 anal cancers 53 MnSOD 53 severe periodontitis 53 neoplasias 53 autoantibodies 53 breast cancer subtypes 53 glycated hemoglobin levels 53 squamous subtype 53 genetic variations 53 subclinical atherosclerosis 53 thyroid cancers 53 vaginal cancers 53 core needle biopsies 53 heterozygosity 53 carotid plaques 53 de novo mutations 53 urinary BPA 53 PARP inhibition 53 Leydig cell 53 prenatally diagnosed 53 chromosomal regions 53 premalignant lesions 53 Cowden syndrome 53 histologically confirmed 53 lung adenocarcinomas 53 heterozygote 53 nonseminoma 53 LTBI 53 alanine aminotransferase ALT 53 familial predisposition 53 CagA 53 meningiomas 53 RET PTC rearrangements 53 cervical abnormalities 53 PCA3 scores 53 Hepatitis B virus 53 shorter telomere length 53 PKCi 53 premature menopause 53 spontaneous mutation 53 HLA DQ2 53 disease NAFLD 53 ALK mutations 53 pancreatic cancers 53 GSTM1 gene 53 hereditary predisposition 53 KRAS oncogene 53 HIV HCV coinfected 53 oesophageal adenocarcinoma 53 estrogen progestin therapy 53 IKZF1 53 serum vitamin D 53 endometrial cancer 53 5q 53 oligodendrogliomas 53 syngeneic 53 genital ulcers 53 colorectal carcinomas 53 taxane therapy 53 glioma rarer 53 gastric carcinoma 53 univariate analyzes 53 malignant polyps 53 microscopic colitis 53 FLT3 53 adnexal mass 53 genetic predisposition 53 tamoxifen therapy 53 folate intake 53 NMIBC 53 idiopathic myelofibrosis 53 prostate carcinoma 53 HPV subtypes 53 diabetes mellitus DM 53 grade cervical intraepithelial 53 K ras mutation 53 fetuin 53 urine cytology 53 LRRK2 gene 53 homozygosity 53 N. gonorrhoeae 53 Multivariate analysis 53 DAT1 53 cervical lesions 53 vertebral fracture 53 carbohydrate intolerance 53 recurrent miscarriage 53 asymptomatically 53 prostate cancers 53 singleton pregnancies 53 KRAS mutation 53 LV dysfunction 53 repeat allele 53 microalbuminuria 53 microsatellite instability 53 mammary tumors 53 mutated BRCA 53 locoregional 53 parathyroid carcinoma 53 aged ≥ 53 HPV infections 53 nonsmall cell lung cancer 53 dizygotic 53 atypical moles 53 latent TB 53 prognostic markers 53 APOL1 53 mammary gland tumors 53 serum PTH 53 nodal metastases 53 ductal carcinomas 53 CYP#D# gene 53 genital tract infections 53 nonhereditary 53 FeNO 53 smoldering myeloma 53 CYP# [002] 53 elevated LDL 53 defective gene 53 genotypes 53 thromboembolisms 53 lymph node metastasis 53 coronary calcification 53 NPM1 mutations 53 BRIP1 52 mammographic density 52 fetal malformations 52 KRAS gene 52 chromosomal anomalies 52 HLA DRB1 52 GABRA2 52 multivariable adjusted 52 HPV infection 52 polymorphisms 52 CHEK2 gene 52 monozygotic 52 promoter methylation 52 colorectal cancer 52 cause cardiac channelopathies 52 Ovary removal 52 gastric adenocarcinoma 52 oral clefts 52 Amniocentesis 52 dysglycemia 52 CYP#D# genotype 52 #p# [001] 52 sentinel node 52 metastatic prostate 52 LRRK2 mutations 52 fraternal twin pairs 52 G6PD deficiency 52 cardiovascular mortality 52 Trichomonas vaginalis 52 lymphatic cancers 52 autosomal recessive disease 52 urethritis 52 MLL2 52 gene polymorphism 52 EUS FNA 52 genetic polymorphism 52 facial clefts 52 pheochromocytomas 52 genital HPV infection 52 low expressors 52 VKORC1 52 SHBG 52 Radical prostatectomy 52 renal carcinoma 52 K#N 52 TMEM density 52 microvascular disease 52 breast lesions 52 chromosomal abnormality 52 somatic mutations 52 seroprevalence 52 congenital abnormalities 52 precancerous cervical lesions 52 ductal 52 seroconverted 52 liver metastasis 52 SUVmax 52 juvenile myelomonocytic leukemia 52 herpesviruses 52 NP CRNs 52 Zolinza 52 missense mutations 52 LRRK2 mutation 52 hyperandrogenism 52 EGFR protein 52 axillary nodes 52 latent celiac disease 52 genes BRCA 52 mutated BRAF gene 52 benign noncancerous 52 genotypic resistance 52 HCV genotype 52 carry BRCA mutation 52 overexpress HER2 52 acute leukemias 52 % CI #.#-#.# [003] 52 Cholangiocarcinoma 52 liver metastases 52 neurodevelopmental impairment 52 nonfasting triglyceride levels 52 cystatin C 52 kaempferol 52 osteoporotic fracture 52 biochemical recurrence 52 K#R [002] 52 atopic 52 abnormal lipid 52 asymptomatic carriers 52 albumin excretion 52 serum concentrations 52 Munk Olsen 52 Uterine fibroids 52 HLA B 52 HER2 overexpression 52 recurrent metastatic 52 metastases 52 seminoma 52 ovarian endometrial 52 asymptomatic hypothyroidism 52 serum lipid levels 52 HBeAg 52 herpes infection 52 sarcosine 52 hematopoietic cancers 52 T#I [002] 52 microscopic hematuria 52 seropositive 52 recurrent UTI 52 Prostatitis 52 onset diabetes mellitus 52 thyrotropin 52 invasive carcinomas 52 IL#B 52 CNVs 52 Gestational 52 familial clustering 52 plasma folate 52 cytogenetic abnormalities 52 heavily pretreated 52 lobular 52 TNF blocker therapy 52 hypovitaminosis D 52 clinically localized prostate 52 undergone radical prostatectomy 52 DRD4 52 asymptomatic carotid stenosis 52 #q#.# [001] 52 precancerous condition 52 nonmetastatic 52 prophylactic mastectomy 52 gestational diabetes mellitus GDM 52 non pledgers 52 mucinous 52 minimally symptomatic metastatic castrate 52 macrosomia 52 nondepressed 52 HLA genes 52 folate concentrations 52 axillary node dissection 52 fetal chromosomal 52 densest breasts 52 ovarian pancreatic 52 troponin T 52 2 diabetes T2D 52 elevated fasting glucose 52 elevated LDH 52 invasive lobular 52 Premenopausal women 52 hamartomas 52 KIF6 gene variant 52 metachronous 52 endometrial hyperplasia 52 carcinomas 52 axillary dissection 52 de ath 52 breast uterine 52 total thyroidectomy 52 NRTI resistance 52 BMI #-#.# 52 EGFR gene 52 CIN3 + 52 AML MDS 52 neoplasia PIN 52 adiponectin concentrations 52 TOP2A 52 telomere lengths 52 Leydig cells 52 MIF protein 52 preventive mastectomy 52 preoperative PSA 52 HLA DRB1 * 52 recurrent ovarian cancer 52 HIV seropositive 52 gastrointestinal cancers 52 promoter hypermethylation 52 unexplained mental retardation 52 PSADT 52 SHBG levels 52 renal tumors 52 microdeletion 52 IgG antibody 52 serum testosterone 52 CAG repeats 52 subtype 52 hyperemesis gravidarum 52 gene expression profiles 51 idiopathic PAH 51 curable cancers 51 Epidemiologic studies 51 Malignant tumors 51 KIT mutations 51 prenatal diagnosis 51 papillary thyroid cancer 51 heritable genetic 51 neoplasms 51 screening colonoscopy 51 Schaffir 51 Lung transplantation 51 CYP#B# 51 precancers 51 acute myelogenous leukemia AML 51 D dimer 51 pilocytic astrocytomas 51 bronchopulmonary dysplasia BPD 51 postmenopausal hormone 51 CVD mortality 51 LPA gene 51 IPAH 51 breast cancer recurrence 51 undergone hysterectomies 51 LRP5 51 K ras 51 immunodeficient 51 benign growths 51 overt hypothyroidism 51 fluoroquinolone resistance 51 preterm deliveries 51 skeletal metastases 51 multivariate logistic regression 51 M#V mutation 51 MC1R 51 TMEM#B 51 HER2 positive metastatic breast 51 extracolonic findings 51 abnormal vaginal bleeding 51 ovarian dysfunction 51 papillary carcinoma 51 malignant nodules 51 GnRH agonists 51 MC1R gene 51 gene polymorphisms 51 antibody titer 51 benign lesions 51 hereditary breast 51 distal colon 51 CFTR gene 51 susceptibility loci 51 lymphocytosis 51 serum uric acid 51 genetic markers 51 virologic failure 51 PGDH 51 transfusion syndrome 51 homozygous FH 51 undescended testicles 51 MHC genes 51 multivariate analyzes 51 leukemia ALL 51 vimentin 51 androgen deficiency 51 RhD 51 inherited gene mutation 51 mL/min/#.# m 2 51 homozygous familial hypercholesterolemia 51 dysplastic lesions caused 51 persistent pulmonary hypertension 51 olaparib 51 ovarian hyperstimulation 51 obese postmenopausal 51 hypermethylation 51 folate intakes 51 polycystic kidneys 51 del 5q 51 Polycystic ovary syndrome 51 neurofibromas 51 SOD2 gene 51 GNAQ 51 chlamydia infections 51 Chronic pancreatitis 51 Genetic predisposition 51 azoospermia 51 trivial Klatsky 51 fetal aneuploidy 51 PNH patients 51 abnormal mammograms 51 PSA nadir 51 molecular abnormalities 51 Genetic variants 51 breast tumors 51 metastatic bladder 51 premenopausal women 51 recurrent ovarian 51 systolic dysfunction 51 Heavy menstrual bleeding 51 Chlamydia infection 51 cancerous polyps 51 B7 H3 51 placenta praevia 51 undergoing hysterectomy 51 radical nephrectomy 51 esophageal cancers 51 karyotype 51 metastatic lesions 51 adiponectin levels 51 intensive statin therapy 51 Testicular cancer 51 cagA 51 selenium intake 51 APOC3 51 Folic acid supplements 51 abnormal pap smear 51 nonischemic 51 PTEN gene 51 endometriosis ovarian cysts 51 folate deficiency 51 nasopharyngeal carcinoma 51 metastatic RCC 51 undergoing radical prostatectomy 51 Clusterin 51 BRCA deficient 51 anal HPV 51 UGT#B# 51 S. maltophilia 51 prevalences 51 colon polyps 51 HBV 51 estrogen receptor 51 urothelial carcinoma 51 proliferative diabetic retinopathy 51 cervical HPV 51 subfertile 51 bronchopulmonary dysplasia 51 clade B 51 IUGR 51 lipid abnormalities 51 obstructive CAD 51 DRD2 51 Prostate specific antigen 51 squamous cell skin 51 ALND 51 prostate cancer CRPC 51 RBC folate 51 clusterin 51 nonpregnant 51 transthyretin 51 HLA DR 51 serum estradiol 51 unexplained infertility 51 inhibin B 51 sleeve lobectomy 51 sero positive 51 retrospective cohort 51 chromosomal defect 51 protein excretion 51 ORMDL3 51 inherited genetic mutation 51 postnatally 51 esophageal squamous cell carcinoma 51 #q#.# deletion syndrome 51 BRAF V#E 51 SPINK1 51 PDGFR 51 KRAS mutations occur 51 miRNA genes 51 PIK3CA